Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03520231
Title Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma


Carboplatin + Cisplatin + Denosumab + Gemcitabine

Carboplatin + Cisplatin + Gemcitabine

Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.